Showing 1 - 10 of 2,778
Inflation for retirees is different from, and mostly higher than, the macroeconomic (average) inflation rate for the entire population. In the U.S. for example, the Consumer Price Index for the Urban population (CPI-U) calculated and reported by the Bureau of Labor Statistics (BLS) has a lesser...
Persistent link: https://www.econbiz.de/10013125606
Persistent link: https://www.econbiz.de/10014306947
The pricing of longevity-linked securities depends not only on the stochastic uncertainty of the underlying risk factors, but also the attitude of investors towards those factors. In this research, we investigate how to estimate the market risk premium of longevity risk using investable...
Persistent link: https://www.econbiz.de/10012927869
uncertainty is referred to as longevity risk. Existing literature shows that the effect of longevity risk on single life annuities … can be substantial, and that there exists a (natural) hedge potential from combining single life annuities with death …
Persistent link: https://www.econbiz.de/10013127855
A general class of fair valuations which are both market-consistent (mark-to-market for any hedgeable part of a claim) and actuarial (mark-to-model for any claim that is independent of financial market evolutions) was introduced in Dhaene et al. in a single period framework. In particular, the...
Persistent link: https://www.econbiz.de/10012925864
There is a significant potential demand in many countries around the world for a flexible product to manage individual longevity risk arising from the prevalence of defined contribution pensions, uncertainty in improvements in life expectancy, potential reductions in public pensions and a lack...
Persistent link: https://www.econbiz.de/10012836433
offered by Variable Annuities in a Lévy market. We address these questions from a risk management perspective. This method …
Persistent link: https://www.econbiz.de/10014147878
Persistent link: https://www.econbiz.de/10013370711
The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...
Persistent link: https://www.econbiz.de/10012959215
We develop a robust optimal dynamic hedging strategy that takes both downside risks and market incompleteness into account for an agent who fears model misspecification. The robust agent is assumed to minimize the shortfall between the assets and liabilities under an endogenous worst case...
Persistent link: https://www.econbiz.de/10012937852